Back to directory
Beckley Psytech Pitch Deck
Stage
Series B
Industry
Other
Year
2019
Updated
March 11, 2026
Raised
$114M
Company detail
Beckley Psytech is a psychedelic medicine company developing a pipeline of psychedelic medicines with significant commercial potential to address unmet clinical needs in mental health.
This Series B deck details a raise of $114,200,000.